Sulperazon-induced acute reactive thrombocytopenia during treatment of systemic lupus erythematosus: a case report

The purpose of this study is to report a patient who developed acute reactive thrombocytopenia while undergoing treatment with sulperazon for systemic lupus erythematosus (SLE). Sulperazon is a broad-spectrum antibiotic that can act against a wide range of microorganisms, but rarely causes severe th...

Descripción completa

Detalles Bibliográficos
Autores principales: Lv, Mengen, Xu, Qing, Ye, Xianfei, Yu, Qian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10359788/
https://www.ncbi.nlm.nih.gov/pubmed/34497130
http://dx.doi.org/10.1136/ejhpharm-2021-002999

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10359788/
https://www.ncbi.nlm.nih.gov/pubmed/34497130
http://dx.doi.org/10.1136/ejhpharm-2021-002999

Ejemplares similares